Signs of mold toxicity mirror symptoms of common health nuisances...but a nationally recognized mold remediator says exposure ...

PEMGARDA (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 millionPreliminary Q4 2024 total operating costs and expenses of approximately ...

Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions ...

Financing led by new Investors Fåhraeus Startup and Growth and EIC FundHELSINKI, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Aplagon, a ...

The Nation Newspaper 'Underage mothers, diseases, delayed healthcare access contributing to maternal mortality in Nigeria' ...